ScholarIQanswers from OpenAlex

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis

PaperCitations, authors & open-access status

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis have?

ScholarIQcitation count

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis has 53 citations in the OpenAlex counts ScholarIQ stores.

When was Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis published?

ScholarIQyear

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis has 2020 year in the ScholarIQ index.

What is the open-access status of Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis?

ScholarIQoa status

Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis has hybrid oa status in the ScholarIQ index.

What is the DOI of Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis?

ScholarIQdoi

The DOI for Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis is on the source record.

What is the PMID of Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis?

ScholarIQpmid

The PMID for Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis is on the source record.

What is the OpenAlex record for Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis?

ScholarIQopenalex

The OpenAlex for Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial